Schroder Investment Management Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-423,684
Closed -$14.8M – 1362
2021
Q4
$14.8M Buy
423,684
+15,340
+4% +$411K 0.02% 537
2021
Q3
$14.4M Hold
408,344
– – 0.02% 550
2021
Q2
$14.9M Buy
408,344
+20,227
+5% +$613K 0.02% 582
2021
Q1
$15.5M Sell
388,117
-273,057
-41% -$8.01M 0.02% 565
2020
Q4
$17.5M Buy
661,174
+554,296
+519% +$10.3M 0.02% 515
2020
Q3
$2.25M Buy
106,878
+13,900
+15% +$239K ﹤0.01% 870
2020
Q2
$2.31M Buy
92,978
+6,508
+8% +$115K ﹤0.01% 799
2020
Q1
$1.78M Sell
86,470
-67,848
-44% -$1.64M ﹤0.01% 815
2019
Q4
$6M Buy
154,318
+73,770
+92% +$1.92M 0.01% 721
2019
Q3
$2.32M Buy
80,548
+17,228
+27% +$394K ﹤0.01% 868
2019
Q2
$2.09M Buy
63,320
+990
+2% +$23.5K ﹤0.01% 926
2019
Q1
$2.06M Sell
62,330
-286,875
-82% -$6.85M ﹤0.01% 807
2018
Q4
$8.82M Buy
349,205
+48,657
+16% +$1.16M 0.02% 578
2018
Q3
$9.97M Sell
300,548
-199,652
-40% -$4.57M 0.02% 602
2018
Q2
$15.5M Sell
500,200
-84,600
-14% -$1.75M 0.03% 527
2018
Q1
$12M Sell
584,800
-529,000
-47% -$9.85M 0.02% 567
2017
Q4
$29.2M Buy
1,113,800
+1,077,300
+2,952% +$17.1M 0.05% 412
2017
Q3
$624K Buy
+36,500
New +$552K ﹤0.01% 1037
2017
Q2
– Sell
-564
Closed -$8K – 1285
2017
Q1
$8K Buy
+564
New +$7.76K ﹤0.01% 1230
2016
Q2
– Sell
-8,504
Closed -$230K – 1161
2016
Q1
$230K Sell
8,504
-800
-9% -$59.2K ﹤0.01% 1021
2015
Q4
$976K Sell
9,304
-31,700
-77% -$3.56M ﹤0.01% 932
2015
Q3
$9.26M Buy
41,004
+31,700
+341% +$7.39M 0.02% 613
2015
Q2
$2.09M Buy
9,304
+8,804
+1,761% +$1.95M ﹤0.01% 831
2015
Q1
$124K Buy
+500
New +$88.7K ﹤0.01% 1104
2013
Q3
– Sell
-8,341
Closed -$718K – 1514
2013
Q2
$718K Buy
+8,341
New +$657K ﹤0.01% 1054

Other funds holding BHC

Schroder Investment Management Group's BHC Position: Q1 2022 in Review

Schroder Investment Management Group sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 423,684 shares — an estimated $14.8M sold.

Schroder Investment Management Group first reported a position in BHC in Q2 2013 and held it in 25 quarters. The position peaked at $29.2M in Q4 2017. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • Schroder Investment Management Group reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 423,684 Bausch Health shares in Q1 2022, an estimated $14.8M.
  • Schroder Investment Management Group first reported a position in Bausch Health in Q2 2013 and held it in 25 quarters.
  • Schroder Investment Management Group's Bausch Health position peaked at $29.2M in Q4 2017.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.